Literature DB >> 25938125

In vivo neuronal co-expression of mu and delta opioid receptors uncovers new therapeutic perspectives.

Eric Erbs1, Lauren Faget1, Pierre Veinante2, Brigitte L Kieffer3, Dominique Massotte4.   

Abstract

Opioid receptors belong to the G protein coupled receptor family. They modulate brain function at all levels of neural integration and therefore impact on autonomous, sensory, emotional and cognitive processing. In vivo functional interaction between mu and delta opioid receptors are known to take place though it is still debated whether interactions occur at circuitry, cellular or molecular level. Also, the notion of receptor crosstalk via mu-delta heteromers is well documented in vitro but in vivo evidence remains scarce. To identify neurons in which receptor interactions could take place, we designed a unique double mutant knock-in mouse line that expresses functional red-fluorescent mu receptors and green-fluorescent delta receptors. We mapped mu and delta receptor distribution and co-localization throughout the nervous system and created the first interactive brain atlas with concomitant mu-delta visualization at subcellular resolution (http://mordor.ics-mci.fr/). Mu and delta receptors co-localize in neurons from subcortical networks but are mainly detected in separate neurons in the forebrain. Also, co-immunoprecipitation experiments indicated physical proximity in the hippocampus, a prerequisite to mu-delta heteromerization. Altogether, data suggest that mu-delta functional interactions take place at systems level for high-order emotional and cognitive processing whereas mu-delta may interact at cellular level in brain networks essential for survival, which has potential implications for innovative drug design in pain control, drug addiction and eating disorders.

Entities:  

Year:  2014        PMID: 25938125      PMCID: PMC4415729          DOI: 10.14800/rci.210

Source DB:  PubMed          Journal:  Receptors Clin Investig


  32 in total

Review 1.  Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies.

Authors:  Xavier Nadal; Carmen La Porta; S Andreea Bura; Rafael Maldonado
Journal:  Eur J Pharmacol       Date:  2013-03-20       Impact factor: 4.432

Review 2.  Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 3.  FoxP2 brainstem neurons project to sodium appetite regulatory sites.

Authors:  Jung-Won Shin; Joel C Geerling; Matthew K Stein; Rebecca L Miller; Arthur D Loewy
Journal:  J Chem Neuroanat       Date:  2011-05-13       Impact factor: 3.052

Review 4.  Organization of the human superior olivary complex.

Authors:  J K Moore
Journal:  Microsc Res Tech       Date:  2000-11-15       Impact factor: 2.769

Review 5.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

Review 6.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Authors:  M R Bruchas; B B Land; C Chavkin
Journal:  Brain Res       Date:  2009-08-28       Impact factor: 3.252

7.  Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats.

Authors:  Bronwyn M Kivell; Darren J Day; Fiona J McDonald; John H Miller
Journal:  Brain Res Dev Brain Res       Date:  2004-03-22

Review 8.  Role of lateral hypothalamic orexin neurons in reward processing and addiction.

Authors:  Gary Aston-Jones; Rachel J Smith; David E Moorman; Kimberlei A Richardson
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

Review 9.  Common brain activations for painful and non-painful aversive stimuli.

Authors:  Dave J Hayes; Georg Northoff
Journal:  BMC Neurosci       Date:  2012-06-07       Impact factor: 3.288

10.  Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors.

Authors:  Edmund W Ong; Catherine M Cahill
Journal:  Cells       Date:  2014-03-05       Impact factor: 6.600

View more
  7 in total

1.  In vivo mapping of a GPCR interactome using knockin mice.

Authors:  Jade Degrandmaison; Khaled Abdallah; Véronique Blais; Samuel Génier; Marie-Pier Lalumière; Francis Bergeron; Catherine M Cahill; Jim Boulter; Christine L Lavoie; Jean-Luc Parent; Louis Gendron
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-26       Impact factor: 11.205

Review 2.  Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.

Authors:  Miguel Pérez de la Mora; Dasiel O Borroto-Escuela; Minerva Crespo-Ramírez; José Del Carmen Rejón-Orantes; Daniel Alejandro Palacios-Lagunas; Magda K Martínez-Mata; Daniela Sánchez-Luna; Emiliano Tesoro-Cruz; Kjell Fuxe
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

3.  Mapping GPR88-Venus illuminates a novel role for GPR88 in sensory processing.

Authors:  Aliza T Ehrlich; Meriem Semache; Julie Bailly; Stefan Wojcik; Tanzil M Arefin; Christine Colley; Christian Le Gouill; Florence Gross; Viktoriya Lukasheva; Mireille Hogue; Emmanuel Darcq; Laura-Adela Harsan; Michel Bouvier; Brigitte L Kieffer
Journal:  Brain Struct Funct       Date:  2017-11-06       Impact factor: 3.270

4.  Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template.

Authors:  Abdelfattah Faouzi; Rajendra Uprety; Ivone Gomes; Nicolas Massaly; Attila I Keresztes; Valerie Le Rouzic; Achla Gupta; Tiffany Zhang; Hye Jean Yoon; Michael Ansonoff; Abdullah Allaoa; Ying Xian Pan; John Pintar; Jose A Morón; John M Streicher; Lakshmi A Devi; Susruta Majumdar
Journal:  J Med Chem       Date:  2020-11-10       Impact factor: 7.446

Review 5.  Neurochemistry of the Kölliker-Fuse nucleus from a respiratory perspective.

Authors:  Adrienn G Varga; Sebastian N Maletz; Jordan T Bateman; Brandon T Reid; Erica S Levitt
Journal:  J Neurochem       Date:  2020-06-10       Impact factor: 5.546

6.  Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions.

Authors:  Arryn T Blaine; Yiming Miao; Jinling Yuan; Sophia Palant; Rebecca J Liu; Zhong-Yin Zhang; Richard M van Rijn
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

Review 7.  Untangling the complexity of opioid receptor function.

Authors:  Rita J Valentino; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2018-09-24       Impact factor: 7.853

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.